LOS ANGELES, CALIFORNIA--(Marketwired - July 23, 2015) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, today announced that it will host a conference call at 4 p.m. EST on Monday, July 27, 2015, providing an introduction to the company's new executive personnel and to clarify the role and shareholdings of the non-executive Chairman and non-executive Vice Chairman.
Participants from PHM will be Casey Hoyt (CEO) and Michael Dalsin (Chairman).
The details of the call are:
| Monday, July 27, 2015 at 4 p.m. EST |
| |
|
| |
US & Canada Toll Free: |
| |
|
| |
Dial In: (855) 886-8711 |
| |
|
| |
Meeting ID Number: 934 120 14 |
About PHM
The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals. PHM is a positive cash flow and profitable company that serves patients with heart disease and other chronic health conditions; this operation is a platform for acquisitions and organic growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM's post-acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.